Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocort versus Solu-Medrol for acute relapse in relapsing-remitting multiple sclerosis or clinically isolated syndrome
2009-013884-21Phase 2Terminated
- Sponsor
- Enceladus Pharmaceuticals
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of hydrocortisone in multiple sclerosis (MS) and clinically isolated syndrome (CIS) (2 arms), sponsored by Enceladus Pharmaceuticals. Started Sep 2009; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on 2009-013884-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013884-21.